In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



Latest From Grupo JUSTE S.A.Q.F

Finance Watch: Lightstone Ventures Closes $375m Fund To Back Early Stage Biotechs

Private Company Edition: Recent biopharma venture capital financings add up to $1.7bn, including a $135m crossover round for HilleVax after spinning out of Takeda in July to advance a norovirus vaccine, Skyhawk’s $133m in fresh funding and Obsidian’s $115m series B round.

Financing Innovation

Pharmanova to commercialise MediGene's Veregen in South-eastern Europe

Germany's MediGene has signed yet another agreement for its treatment for genital warts, Veregen ointment (previously Polyphenon E), the latest deal being with Serbian company, Pharmanova, which will supply and commercialise the product in South-eastern Europe. The territories covered by the agreement include Serbia, Bosnia and Herzegovina, Montenegro, Macedonia, Croatia, Slovenia, and Albania.


MediGene licenses Veregen in Taiwan

The German biotech company MediGene has signed another licence and supply agreement for the commercialisation and marketing of Veregen (previously Polyphenon E) ointment for the treatment of genital warts, this time with SynCore Biotechnology in Taiwan.


Deals Shaping the Medical Industry (05/2010)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

See All

Company Information

  • Industry
  • Pharmaceuticals
    • Radiopharmaceuticals, Contrast Agents
  • Other Names / Subsidiaries
    • Justesa Imagen
    • Juste Farma